The life and fate of mesenchymal stem cells

Frontiers in Immunology

Volumn 5, Issue MAY, 2014, Pages

  Eggenhofer, Elke ^a   Luk, Franka ^b   Dahlke, Marc H ^a   Hoogduijn, Martin J ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Culture; Homing; Mesenchymal stem cells; Migration; Survival

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE;

CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; REGENERATIVE MEDICINE; REGULATORY T LYMPHOCYTE; REVIEW; TISSUE REGENERATION; TISSUE REPAIR;

EID: 84905500026     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00148     Document Type: Review

References (51)

1. Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell (2013) 13(4):392-402. doi: 10.1016/j.stem.2013.09.006
2. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science (1997) 276(5309):71-4. doi:10.1126/science.276.5309.71
3. Togel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol (2007) 292(5):F1626-35. doi:10.1152/ajprenal.00339.2006
4. Hocking AM, Gibran NS. Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res (2010) 316(14):2213-9. doi:10.1016/j.yexcr.2010.05.009
5. Eggenhofer E, Benseler V, Kroemer A, Popp FC, Geissler EK, Schlitt HJ, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol (2012) 3:297. doi:10.3389/fimmu.2012.00297
6. Liu XB, Chen H, Chen HQ, Zhu MF, Hu XY, Wang YP, et al. Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantation. J Zhejiang Univ Sci B (2012) 13(8):616-23. doi:10.1631/jzus.B1201004
7. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells (2007) 25(7):1737-45. doi:10.1634/stemcells.2007-0054
8. Wagner W, Ho AD, Zenke M. Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev (2010) 16(4):445-53. doi:10.1089/ten.TEB.2009.0825
9. Rombouts WJ, Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia (2003) 17(1):160-70. doi:10.1038/sj.leu.2402763
10. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev (2009) 18(5):683-92. doi:10.1089/scd.2008.0253
11. Eggenhofer E, Popp FC, Mendicino M, Silber P, Hof VW, Renner P, et al. Heart grafts tolerized through third-party multipotent adult progenitor cells can be retransplanted to secondary hosts with no immunosuppression. Stem Cells Transl Med (2013) 2(8):595-606. doi:10.5966/sctm.2012-0166
12. Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M, et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells (2005) 23(8):1105-12. doi:10.1634/stemcells.2004-0330
13. Meirelles SL, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci (2006) 119(Pt 11):2204-13. doi:10.1242/jcs.02932
14. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol (2003) 121(2):368-74. doi:10.1046/j.1365-2141.2003.04284.x
15. Alm JJ, Koivu HM, Heino TJ, Hentunen TA, Laitinen S, Aro HT. Circulating plastic adherent mesenchymal stem cells in aged hip fracture patients. J Orthop Res (2010) 28(12):1634-42. doi:10.1002/jor.21167
16. Rochefort GY, Delorme B, Lopez A, Herault O, Bonnet P, Charbord P, et al. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells (2006) 24:2202-8. doi:10.1634/stemcells.2006-0164
17. Chen Y, Xiang LX, Shao JZ, Pan RL, Wang YX, Dong XJ, et al. Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver. J Cell Mol Med (2010) 14(6B):1494-508. doi:10.1111/j.1582-4934.2009.00912.x
18. Gil-Ortega M, Garidou L, Barreau C, Maumus M, Breasson L, Tavernier G, et al. Native adipose stromal cells egress from adipose tissue in vivo: evidence during lymph node activation. Stem Cells (2013) 31(7):1309-20. doi:10.1002/stem.1375
19. Hoogduijn MJ, Crop MJ, Peeters AM, Korevaar SS, Eijken M, Drabbels JJ, et al. Donor-derived mesenchymal stem cells remain present and functional in the transplanted human heart. Am J Transplant (2009) 9(1):222-30. doi:10.1111/j.1600-6143.2008.02450.x
20. Lama VN, Smith L, Badri L, Flint A, Andrei AC, Murray S, et al. Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest (2007) 117(4):989-96. doi:10.1172/JCI29713
21. Jin SZ, Liu BR, Xu J, Gao FL, Hu ZJ, Wang XH, et al. Ex vivo-expanded bone marrow stem cells home to the liver and ameliorate functional recovery in a mouse model of acute hepatic injury. Hepatobiliary Pancreat Dis Int (2012) 11(1):66-73. doi:10.1016/S1499-3872(11)60127-6
22. Jackson JS, Golding JP, Chapon C, Jones WA, Bhakoo KK. Homing of stem cells to sites of inflammatory brain injury after intracerebral and intravenous administration: a longitudinal imaging study. Stem Cell Res Ther (2010) 1(2):17. doi:10.1186/scrt17
23. Assis AC, Carvalho JL, Jacoby BA, Ferreira RL, Castanheira P, Diniz SO, et al. Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplant (2010) 19(2):219-30. doi:10.3727/096368909X479677
24. 44 following acute tubular injury. Kidney Int (2007) 72(4):430-41. doi:10.1038/sj.ki.5002334
25. 4-overexpressing bone marrow-derived mesenchymal stem cells improve repair of acute kidney injury. Am J Physiol Renal Physiol (2013) 305(7):F1064-73. doi:10.1152/ajprenal.00178.2013
26. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation (2003) 108(7):863-8. doi:10.1161/01.CIR.0000084828.50310.6A
27. Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P, et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation (2005) 112(10):1451-61. doi:10.1161/CIRCULATIONAHA.105.537480
28. Lu W, Fu C, Song L, Yao Y, Zhang X, Chen Z, et al. Exposure to supernatants of macrophages that phagocytized dead mesenchymal stem cells improves hypoxic cardiomyocytes survival. Int J Cardiol (2013) 165(2):333-40. doi:10.1016/j.ijcard.2012.03.088
29. Kunter U, Rong S, Djuric Z, Boor P, Muller-Newen G, Yu D, et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol (2006) 17(8):2202-12. doi:10.1681/ASN.2005080815
30. Zhong Y, Tang Z, Xu R, Lin N, Deng M, Fang H, et al. Effect of transplantation route on stem cell migration to fibrotic liver of rats via cellular magnetic resonance imaging. Cytotherapy (2013) 15(10):1266-74. doi:10.1016/j.jcyt.2013.05.023
31. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A (2005) 102(32):11474-9. doi:10.1073/pnas.0504388102
32. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol (1976) 4(5):267-74.
33. Maumus M, Peyrafitte JA, D'Angelo R, Fournier-Wirth C, Bouloumie A, Casteilla L, et al. Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes (Lond) (2011) 35(9):1141-53. doi:10.1038/ijo.2010.269
34. 105 accompanies mesenchymal stromal cell derivation from human adventitial stromal cell. Stem Cells Dev (2013) 22(5):815-27. doi:10.1089/scd.2012.0263
35. Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A (2000) 97(7):3213-8. doi:10.1073/pnas.97.7.3213
36. Crop MJ, Baan CC, Korevaar SS, Ijzermans JN, Pescatori M, Stubbs AP, et al. Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clin Exp Immunol (2010) 162(3):474-86. doi:10.1111/j.1365-2249.2010.04256.x
37. Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP. Stem cell transplantation: the lung barrier. Transplant Proc (2007) 39(2):573-6. doi:10.1016/j.transproceed.2006.12.019
38. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood (2006) 107(4):1484-90. doi:10.1182/blood-2005-07-2775
39. Crop MJ, Korevaar SS, de Kuiper R, JN IJ, van Besouw NM, Baan CC, et al. Human mesenchymal stem cells are susceptible to lysis by CD8(+) T cells and NK cells. Cell Transplant (2011) 20(10):1547-59. doi:10.3727/096368910X564076
40. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation (1968) 6(2):230-47. doi:10.1097/00007890-196803000-00009
41. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science (1999) 284(5411):143-7. doi:10.1126/science.284.5411.143
42. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med (1999) 5(3):309-13. doi:10.1038/6529
43. Otsuru S, Gordon PL, Shimono K, Jethva R, Marino R, Phillips CL, et al. Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood (2012) 120(9):1933-41. doi:10.1182/blood-2011-12-400085
44. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol (2005) 289(1):F31-42. doi:10.1152/ajprenal.00007.2005
45. Melief SM, Schrama E, Brugman MH, Tiemessen MM, Hoogduijn MJ, Fibbe WE, et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells (2013) 31(9):1980-91. doi:10.1002/stem.1432
46. 3 gene DNA. Clin Exp Immunol (2013) 173(2):343-54. doi:10.1111/cei.12120
47. 2,3-dioxygenase expression. Transplantation (2010) 90(12):1312-20. doi:10.1097/TP.0b013e3181fed001
48. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med (2009) 15(1):42-9. doi:10.1038/nm.1905
49. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol (2013) 229(2):176-85. doi:10.1002/path.4133
50. Ben-Mordechai T, Holbova R, Landa-Rouben N, Harel-Adar T, Feinberg MS, Abd Elrahman I, et al. Macrophage subpopulations are essential for infarct repair with and without stem cell therapy. J Am Coll Cardiol (2013) 62(20):1890-901. doi:10.1016/j.jacc.2013.07.057
51. Hoogduijn MJ, Rhijn RM, Engela AU, Korevaar SS, Mensah FK, Franquesa M, et al. Mesenchymal stem cells induce an inflammatory response after intravenous infusion. Stem Cells Dev (2013) 22:2825-35. doi:10.1089/scd.2013.0193